Healthcare Nuclear Medicine Radiopharmaceuticals 
Imaging Technology
NOVEMBER 7, 2024
Under the new policy, CMS will unpackage and pay separately for diagnostic radiopharmaceuticals with per-day costs exceeding $630, removing financial barriers that have long hindered patient access to essential nuclear medicine diagnostic procedures. This win is truly a community achievement,” said Cutler. “We
AuntMinnie
OCTOBER 14, 2024
The article was published October 10 in the Journal of Nuclear Medicine. These SSTRs can be targeted both with gallium-68 (Ga-68) imaging agents and therapeutic lutetium-177 (Lu-177) radiopharmaceuticals using a so-called theranostics approach. healthcare setting, they wrote. The full article is available here.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
AuntMinnie
JUNE 3, 2024
With therapeutic radiopharmaceuticals coming to market quickly and available to smaller institutions around the U.S., My vision of a theranostic center includes a flagship facility that has a PET/CT scanner, a SPECT/CT scanner, and then multiple rooms for infusions of radiopharmaceuticals," Siegel explained.
AuntMinnie
OCTOBER 25, 2024
Louis, MO A first-time Minnies finalist, Dmitry Beyder exemplifies how the role of the nuclear medicine technologist can evolve. Beyder played a key role in launching the radiopharmaceutical therapy (RPT) comprehensive center of excellence at WU, BJH, and Siteman Cancer Center last year. Dmitry Beyder.
AuntMinnie
NOVEMBER 12, 2024
Beyder played a key role in launching the radiopharmaceutical therapy (RPT) comprehensive center of excellence at WU, BJH, and Siteman Cancer Center last year. Looking back, he said a family promise led him into healthcare, and whether intentional about it or not, he's been ambitious to better healthcare since coming to the U.S.
Imaging Technology
JUNE 15, 2023
The clinical trial will use this investigational radiopharmaceutical to help understand if patients have CD8+ T cells in their tumors and will, therefore, be more likely to respond to immune checkpoint inhibitors, the main class of immunotherapies currently approved for use.
AuntMinnie
JUNE 9, 2024
Jean-Luc Urbain, MD, PhD, has been named president-elect of the Society of Nuclear Medicine and Molecular Imaging (SNMMI). Urbain, a professor of radiology and nuclear medicine, has served in multiple roles within SNMMI, in addition to his most recent post as vice president-elect. Jean-Luc Urbain, MD, PhD. “As
Expert insights. Personalized for you.
97 
Let's personalize your content